These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51 related articles for article (PubMed ID: 14055229)
1. [NEUROPSYCHIATRIC DISORDERS IN THE TREATMENT OF PULMONARY TUBERCULOSIS WITH CYCLOSERINE]. KAMINSKA M; SERBENSKA PANCZYJ Z Gruzlica (1926); 1963 Aug; 31():875-81. PubMed ID: 14055229 [No Abstract] [Full Text] [Related]
2. [PSYCHIC DISORDERS IN CYCLOSERINE THERAPY OF PULMONARY TUBERCULOSIS]. KOROL II Zh Nevropatol Psikhiatr Im S S Korsakova; 1964; 64():1575-7. PubMed ID: 14328188 [No Abstract] [Full Text] [Related]
3. [PSYCHIC DISORDERS DURING CYCLOSERINE THERAPY OF PULMONARY TUBERCULOSIS]. KUTSENOK BM Zh Nevropatol Psikhiatr Im S S Korsakova; 1964; 64():1572-4. PubMed ID: 14328187 [No Abstract] [Full Text] [Related]
4. [MENTAL SIDE EFFECTS DURING THE USE OF CYCLOSERINE]. MYCZKOWSKA WILSKA E; WISNIEWSKA L Gruzlica (1926); 1965 Feb; 33():117-20. PubMed ID: 14331699 [No Abstract] [Full Text] [Related]
5. PSYCHOSIS ASSOCIATED WITH CYCLOSERINE. BANKIER RG Can Med Assoc J; 1965 Jul; 93(1):35-7. PubMed ID: 14308907 [No Abstract] [Full Text] [Related]
6. SIDE EFFECTS OF AN ANTITUBERCULOUS FIVE-DRUG REGIMEN: ETHIONAMIDE, CYCLOSERINE, PYRAZINAMIDE, VIOMYCIN AND ISONIAZID. TANI P; POPPIUS H Acta Tuberc Pneumol Scand; 1963; 43():256-64. PubMed ID: 14072347 [No Abstract] [Full Text] [Related]
8. [Unmotivated suicide as a most serious complication in the treatment of pulmonary tuberculosis using D-cycloserine]. Schumann C Z Tuberk Erkr Thoraxorg; 1968 Dec; 129(5):295-302. PubMed ID: 5756628 [No Abstract] [Full Text] [Related]
9. [CYCLOSERINE IN THE TREATMENT OF PULMONARY TUBERCULOSIS. OBSERVATIONS IN 45 PATIENTS]. RUBIOPALACIOS H; RODRIGUEZ J Rev Esp Tuberc; 1963 Dec; 32():573-83. PubMed ID: 14125666 [No Abstract] [Full Text] [Related]
10. [Psychiatric and neurological symptoms caused by cycloserine poisoning]. Nakamura K Seishin Shinkeigaku Zasshi; 1968 Jun; 70(6):503-21. PubMed ID: 5749977 [No Abstract] [Full Text] [Related]
11. [ATTEMPTED PSYCHOSOMATIC APPROACH TO THE NEUROTOXICITY OF CYCLOSERINE]. REYSS-BRION R; MEYER L J Med Lyon; 1963 Nov; 44():1619-40. PubMed ID: 14094194 [No Abstract] [Full Text] [Related]
12. [Prevention of neuropsychiatric disorders in pulmonary tuberculotics treated with cycloserine]. OSEGLIA G; SALVETTI F Minerva Med; 1959 Oct; 50():3305-6. PubMed ID: 14429207 [No Abstract] [Full Text] [Related]
13. Clinical experience with cycloserine in the treatment of tuberculosis. Mitchell RS; Lester W Scand J Respir Dis Suppl; 1970; 71():94-108. PubMed ID: 4917144 [No Abstract] [Full Text] [Related]
14. [Results of 2 or 3 secondary drug combinations in the retreatment of chronic pulmonary tuberculosis]. De March Ayuela P; Turell Gumá J Rev Clin Esp; 1968 Apr; 109(2):117-26. PubMed ID: 4904020 [No Abstract] [Full Text] [Related]
15. [Neuropsychiatric disorders & EEG changes during cycloserine therapy of pulmonary tuberculosis]. NAQUET R; RESENDE J; BROUILLET F; SOULAYROL R Ann Med Psychol (Paris); 1958 Mar; 116 Vol 1(3):462-72. PubMed ID: 13571664 [No Abstract] [Full Text] [Related]
16. [Studies on the treatment of pulmonary tuberculosis with cycloserine. III. Toxic effects]. de ALEMQUER J Med (Oporto); 1960 Jul; 42():509-12. PubMed ID: 13792553 [No Abstract] [Full Text] [Related]
17. [Preliminary report on psychoses developing after the administration of cycloserine]. PETROVA J; TOPOLCAN O Cesk Psychiatr; 1963 Feb; 59():20-3. PubMed ID: 13942926 [No Abstract] [Full Text] [Related]